Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

9,784 public trials 1,781 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Active, not recruiting

Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab [IIT2018-04-MCARTHUR-NEOHP]

NCT03747120

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • New Mexico Cancer Center Albuquerque, New Mexico, United States
  • Providence Cancer Institute Portland, Oregon, United States
View Trial Details
Active, not recruiting

DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)

NCT04567420

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
View all 19 locations
View Trial Details
Active, not recruiting

(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer

NCT05607004

Conditions
Breast Diseases, Breast Neoplasms, Estrogen-receptor-positive Breast Cancer, +6 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • University of Arizona Tucson, Arizona, United States
  • California Research Institute Los Angeles, California, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
View all 14 locations
View Trial Details
Active, not recruiting

Cyclophosphamide and Veliparib in Treating Patients With Locally Advanced or Metastatic Breast Cancer

NCT01351909

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced Unresectable Breast Carcinoma, +9 more
Locations
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, United States
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York, United States
  • Montefiore Medical Center-Einstein Campus The Bronx, New York, United States
  • Montefiore Medical Center-Weiler Hospital The Bronx, New York, United States
View Trial Details
Active, not recruiting

Palbociclib in Combination With Bicalutamide for the Treatment of AR(+) Metastatic Breast Cancer (MBC)

NCT02605486

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer (MBC), +4 more
Locations
  • Memorial Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States
  • Memorial Sloan Kettering Westchester Harrison, New York, United States
View Trial Details
Active, not recruiting

Study of Neoadjuvant Olaparib Monotherapy and Olaparib and Durvalumab Combination in HER2 Negative BRCAm Breast Cancer

NCT05498155

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Research Site Greeley, Colorado, United States
  • Research Site Loveland, Colorado, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site Portland, Oregon, United States
View all 37 locations
View Trial Details
Active, not recruiting

A Phase IIIB Study to Evaluate the Use of Capivasertib in Combination With Fulvestrant in Patients With Advanced Breast Cancer Who Have Relapsed/Progressed on ET and CDK4/6 Inhibitor Reflecting Real World Clinical Practice in Spain

NCT06764186

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced or Metastatic Breast Cancer, +4 more
Locations
  • Research Site Alicante, Spain
  • Research Site Barcelona, Spain
  • Research Site Barcelona, Spain
  • Research Site Barcelona, Spain
View all 17 locations
View Trial Details

Related conditions